| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 08/25/2009 | US7579457 Sequence specific gene silencing; antisense agents |
| 08/25/2009 | US7579456 Aptamer therapeutics useful in the treatment of complement-related disorders |
| 08/25/2009 | US7579455 Antisense agents against genes coding for phosphodiesterase; for treatment of asthma, chronic obstructive pulmonary disease (COPD), acute respiratory distress syndrome, bronchitis, chronic bronchitis, silicosis, pulmonary fibrosis, lung allograft rejection, allergic rhinitis and chronic sinusitis |
| 08/25/2009 | US7579454 Method for detecting gram-positive bacteria |
| 08/25/2009 | US7579453 comprehensive collection of single nucleotide polymorphisms (SNPs) in bitter taste receptor (T2R) genes; a portion of these SNPs define biologically relevant difference between different alleles of the bitter taste receptor genes; allelic information is useful in the development of flavoring and enhancer |
| 08/25/2009 | US7579452 immunogenic composition comprising a polynucleotide encoding a nonfunctional mutant Brother of Regulator of Imprinted Sites (BORIS) protein; vaccine against cancer; biodrug delivery of specific nucleic acid |
| 08/25/2009 | US7579450 Aptamers capable of binding to Immunoglobulin E ("IgE") useful as therapeutics in and diagnostics of atopic disease and/or other diseases or disorders in which IgE has been implicated; allergic rhinitis, atopic dermatitis, asthma, acute urticaria, food allergies, peanut allergy, systemic anaphylaxis |
| 08/25/2009 | US7579447 Antibodies against LLG polypeptides of the triacylglycerol lipase family |
| 08/25/2009 | US7579446 Rabies virus G protein specific immunoglobulin for use in prevention and treatment of viral infections |
| 08/25/2009 | US7579443 Lyases; improved ethanol biosynthesis, stalk and nodal strength |
| 08/25/2009 | US7579441 Interleukins; immunoglobulins; for stimulating proliferation and/or development of hematopoietic cells in vitro and in vivo |
| 08/25/2009 | US7579439 Modulation of IL-2- and IL-15-mediated T cell responses |
| 08/25/2009 | US7579438 Use of the gene NcSAG4 for the diagnosis and prevention of neosporosis and as a marker for analysis of the pathogenesis |
| 08/25/2009 | US7579330 Methods of treating various cancers using melanoma differentiation associated protein-7 |
| 08/25/2009 | US7579328 DNA vaccination for treatment of multiple sclerosis and insulin-dependent diabetes mellitus |
| 08/25/2009 | US7579327 Isolated polynucleotide sequences; controlling neovasculization; cell growth regulators |
| 08/25/2009 | US7579326 Gene switch systems employing regulators with decreased dimerization |
| 08/25/2009 | US7579186 Human monoclonal antibody against TGF-β type II receptor and medicinal use thereof |
| 08/25/2009 | US7579181 Purification of adenovirus and AAV |
| 08/25/2009 | US7579180 Polypeptides and nucleic acid molecules encoding the polypeptide; such molecules have use as probes for diagnosis of Alzheimer's disease, and for identification of compounds that modulate the activity of beta secretase |
| 08/25/2009 | US7579175 Aqueous culture product using power source; containing aldolase or synthetase |
| 08/25/2009 | US7579174 Propagating thraustochytriales and using as bioreactors for fermentation of polyunsaturated fatty acids (docosahexaenoic acid ); aerobic processing |
| 08/25/2009 | US7579172 Method and apparatus for amplifying nucleic acids |
| 08/25/2009 | US7579171 Transgenic yeast comprising nucleotide sequences coding L-galactose dehydrogenase (LGDH) for use as enhanced source for generating vitamin c; bioreactor |
| 08/25/2009 | US7579170 Method for preparing monoclonal antibodies capable of activating effector cells expressing FCγRIII |
| 08/25/2009 | US7579169 producing a mutant HH polypeptide by transforming isolated host cells with a vector capable of expressing the polypeptide from the nucleic acid sequence; diagnosis, prenatal screening and diagnosis, and therapies of blood disorders |
| 08/25/2009 | US7579168 Human Dickkopf-related nucleic acid molecules |
| 08/25/2009 | US7579167 Polypeptides involved in the biosynthesis of spiramycins, nucleotide sequences encoding these polypeptides and applications thereof |
| 08/25/2009 | US7579166 lysosomal enzyme having a mannose-6-phosphate-containing acidic sugar chain; a labeling marker for transporting into lysosomes; used as a drug effective in treatment of human lysosomal enzyme deficiencies |
| 08/25/2009 | US7579157 Antibody selection method against IGF-IR |
| 08/25/2009 | US7579150 Mobile RNA acts as a signal to regulate plant growth and development |
| 08/25/2009 | US7579148 detecting differential gene expression of a specific nucleotide sequence that may be found in DNA, RNA, cDNA, PNA, genomic DNA, or synthetic oligonucleotides; systemic lupus erythematosis; polymerase chain reaction |
| 08/25/2009 | US7579146 Double stranded DNA molecule with a single stranded overhang comprised of RNA; cyclic nucleic acid amplification; directed protein evolution |
| 08/25/2009 | US7579142 Methods for purification of bacterial cells and components |
| 08/25/2009 | US7579141 Method of in vitro diagnosis which discriminates between exposure of a subject to Mycobacterium tuberculosis and vaccination with Bacille Calmette Guerin strain of Mycobacterium bovis, method comprising testing for presence of CD4 T lymphocytes that respond to MTBN4 |
| 08/25/2009 | US7579011 isolated polypeptide use in vaccines against A. salmonicida infections such as fish disease furunculosis |
| 08/25/2009 | US7579007 Production of “biological carriers” for induction of immune responses and inhibition of viral replication |
| 08/25/2009 | US7578998 Chimeric cytokine of IL-7 and beta-chain of HGF and methods of use |
| 08/25/2009 | US7578915 Hydrophilic polymeric gel; capillary separation |
| 08/25/2009 | CA2636876A1 Methods and kits for expanding hematopoietic stem cells |
| 08/25/2009 | CA2395539C Soluble interleukin-20 receptor |
| 08/25/2009 | CA2385302C Receptor proteins specifically recognizing bacterial dna |
| 08/25/2009 | CA2382521C Oligonucleotide n3'.fwdarw.p5' thiophosphoramidates: their synthesis and use |
| 08/25/2009 | CA2372456C Viral infection inhibitor targeting integrase n-terminal domain |
| 08/25/2009 | CA2368217C Bacterial cell component-unresponsive model mouse |
| 08/25/2009 | CA2365276C Method for producing polyhydroxyalkanoates in recombinant organisms |
| 08/25/2009 | CA2309600C Low-temperature inducible expression vector |
| 08/25/2009 | CA2157476C Mutant luciferases |
| 08/25/2009 | CA2088889C Specific antibodies against activated platelets, the preparation thereof and the use thereof in diagnosis and therapy |
| 08/22/2009 | CA2619858A1 Brassica juncea lines with high oleic acid profile in seed oil |
| 08/22/2009 | CA2619029A1 New cell technologies |
| 08/20/2009 | WO2009103018A2 Methods and kits for extraction of dna |
| 08/20/2009 | WO2009102995A1 Yeast cells expressing tar dna-binding protein 43 and uses therefor |
| 08/20/2009 | WO2009102971A1 Zea mays aba signaling genes and methods of use |
| 08/20/2009 | WO2009102965A2 Drought and heat tolerance in plants |
| 08/20/2009 | WO2009102931A1 Rnai-mediated inhibition of connexin 43 for treatment of iop-related conditions |
| 08/20/2009 | WO2009102927A1 Improved methods for producing specific binding pairs |
| 08/20/2009 | WO2009102896A2 Isothermal nucleic acid amplification methods and compositions |
| 08/20/2009 | WO2009102894A2 Arginine-conjugated bioreducible poly (disulfide amine) polymers for gene delivery systems |
| 08/20/2009 | WO2009102878A2 Method for archiving and clonal expansion |
| 08/20/2009 | WO2009102873A1 Soybean plant and seed corresponding to transgenic event mon87769 and methods for detection thereof |
| 08/20/2009 | WO2009102755A1 Enzyme with microbial lysis activity from trichoderma reesei |
| 08/20/2009 | WO2009102569A2 Cell lines and methods for making and using them |
| 08/20/2009 | WO2009102469A2 Regulation of cyclin d |
| 08/20/2009 | WO2009102438A2 Aptamer inhibitors of osteopontin and methods of use thereof |
| 08/20/2009 | WO2009102427A2 Modified rnai polynucleotides and uses thereof |
| 08/20/2009 | WO2009102421A2 Targeted therapeutics based on engineered proteins that bind egfr |
| 08/20/2009 | WO2009102357A2 Hiv-1 envelope glycoprotein oligomer and methods of use |
| 08/20/2009 | WO2009102225A2 Method to inhibit ribonuclease dicer, ribonuclease dicer inhibitor, and use of rna aptamers as ribonuclease dicer inhibitors |
| 08/20/2009 | WO2009102085A1 Expression vector suitable for expression of a coding sequence for gene therapy |
| 08/20/2009 | WO2009102081A1 Cyclic single-stranded nucleic acid complex and method for producing the same |
| 08/20/2009 | WO2009102080A1 Vector for screening antibody |
| 08/20/2009 | WO2009101968A1 Anti-adam-15 antibodies and utilization of the same |
| 08/20/2009 | WO2009101945A1 Method of producing s-adenosylmethionine |
| 08/20/2009 | WO2009101942A1 Screening method |
| 08/20/2009 | WO2009101939A1 Non-human mammal model of epilepsy |
| 08/20/2009 | WO2009101807A1 Peptide, use of the peptide, method for production of the peptide, solid support having the peptide immobilized thereon, and method for production of the solid support |
| 08/20/2009 | WO2009101737A1 Protein expression vector tagged with peptide having methionine residue |
| 08/20/2009 | WO2009101700A1 Bioassay method for yokkansan |
| 08/20/2009 | WO2009101672A1 Fused protein containing insulin precursor of overexpression and secretion type, dna encoding the same and method of producing insulin |
| 08/20/2009 | WO2009101403A1 Hybrid polypeptides comprising gbs-80 and spb1 proteins of streptococcus |
| 08/20/2009 | WO2009101400A2 Methods |
| 08/20/2009 | WO2009101399A1 Treatment of muscular dystrophy using peptide nucleic acid ( pna) |
| 08/20/2009 | WO2009101383A1 Mutant proteins and methods for selecting them |
| 08/20/2009 | WO2009101225A1 Pharmaceutical composition for cancer treatment |
| 08/20/2009 | WO2009101213A1 Chitinosanase |
| 08/20/2009 | WO2009101204A2 Elimination of immune responses to viral vectors |
| 08/20/2009 | WO2009101160A1 Production of glycosylated polypeptides in microalgae |
| 08/20/2009 | WO2009101126A1 Method for producing sclareol |
| 08/20/2009 | WO2009100990A1 Process for the production of a peptide |
| 08/20/2009 | WO2009100955A1 Antisense rna targeting cxcr4 |
| 08/20/2009 | WO2009100928A1 Antigen specific regulatory t-cell induction |
| 08/20/2009 | WO2009100674A1 A method of utilizing rdl1 gene to promote seed enlargement and cotton fiber elongation |
| 08/20/2009 | WO2009100521A1 Methods using ion exchange and gel filtration chromatography for poxvirus purification |
| 08/20/2009 | WO2009100502A1 Immunostimulatory sirna molecules |
| 08/20/2009 | WO2009082208A3 Trichome specific promoters |
| 08/20/2009 | WO2009079731A3 Vaccine comprising toxoplasma gondii surface proteins |
| 08/20/2009 | WO2009077618A3 A host cell deficient for murf1 and murf2 |
| 08/20/2009 | WO2009073527A3 Methods and compositions for reducing activity of the atrial natriuretic peptide receptor and for treatment of diseases |
| 08/20/2009 | WO2009073104A3 Simian e adenoviruses sadv-39, -25. 2, -26, -30, -37, and -38 |